Todd Sperry

Todd Sperry is a seasoned pharmaceutical professional with extensive experience in commercial operations and training. Currently serving as Southeast Regional Business Director at BioCryst Pharmaceuticals, Inc. since July 2020, Todd is instrumental in driving business performance and supporting the launch of the company's approved product in the Southeast region. Previously, Todd held the position of Genetic Diagnostic Liaison at Spark Therapeutics, Inc., where responsibilities included promoting gene therapy products to various eye care specialists. Todd's career also includes significant roles at Takeda as Senior Immunology Business Manager, focusing on ultra-orphan drugs for Hereditary Angioedema, and multiple positions at Shire and ViroPharma, promoting critical treatments in the rare disease sector. Todd's expertise in ultra-orphan drugs and rare disease management is well recognized in the industry. Todd's academic background comes from Middle Tennessee State University.